Search PDMR transactions

Notifier
Name of person with notification obligation
Mats Blom
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Mats Blom
Position
Chairman of the Board of Directors
Initial notification
No
Amendment
Yes
Details of amendment
Felstavning
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Egetis Therapeutics AB (publ)
Issuer´s LEI code
549300RZCKGWRUBPMY22
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Egetis Therapeutics AB SE0003815604 Acquisition 180,000 Quantity 5.24 SEK 25/11/2025 NASDAQ STOCKHOLM AB
Share Egetis Therapeutics AB SE0003815604 Acquisition 35,000 Quantity 4.29 SEK 26/11/2025 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Egetis Therapeutics AB SE0003815604 Acquisition 25/11/2025 NASDAQ STOCKHOLM AB 180,000 (Quantity) 5.24 SEK
Egetis Therapeutics AB SE0003815604 Acquisition 26/11/2025 NASDAQ STOCKHOLM AB 35,000 (Quantity) 4.29 SEK
Total: 215,000
<< Back